ReviewInternational journal of molecular sciences2020

Targeted Molecular Therapeutics for Bladder Cancer-A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?

Olga Bednova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.